ENDRA LIFE SCIENCES INC. Other Research and Development Expense
ENDRA LIFE SCIENCES INC. (NDRA) reported Other Research and Development Expense of $381.06 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherResearchAndDevelopmentExpense · last filed 2025-08-14
- ENDRA LIFE SCIENCES INC. other research and development expense for the quarter ending 2025-06-30 was $381.06K, a 46.81% decline year-over-year.
- ENDRA LIFE SCIENCES INC. other research and development expense for the quarter ending 2025-03-31 was $528.68K, a 49.24% decline year-over-year.
- ENDRA LIFE SCIENCES INC. other research and development expense for the quarter ending 2024-06-30 was $716.37K.
- ENDRA LIFE SCIENCES INC. other research and development expense for the quarter ending 2024-03-31 was $1.04M.
| Period end | Other Research and Development Expense 3 month | Other Research and Development Expense 6 month |
|---|---|---|
| 2025-06-30 | $381.06K 10-Q · filed 2025-08-14 | $909.75K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $528.68K 10-Q · filed 2025-05-15 | |
| 2024-06-30 | $716.37K 10-Q · filed 2025-08-14 | $1.76M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $1.04M 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |